この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. Sean V.に依頼
Canada
PhD Biochemistry | Expert in pharmaceuticals, clinical trials, oncology and stem cells
プロフィール概要
専門分野
サービス
Writing
Clinical Trial Documentation,
Medical Writing,
Non-Medical Regulatory Writing,
Technical Writing,
Newswriting,
General Proofreading & Editing
Research
Meta-Research,
Feasibility Study,
Technology Scouting,
Fact Checking,
Gap Analysis,
Scientific and Technical Research,
Systematic Literature Review
Consulting
Business Strategy Consulting,
Scientific and Technical Consulting,
Regulatory Consulting
Data & AI
Statistical Analysis,
Image Processing,
Image Analysis,
Data Cleaning,
Data Processing
職務経験
Postdoctoral Researcher
McMaster University
- 現在 ![]()
Postdoctoral Researcher
McMaster University
1月 2025 - 現在
Clinical Trial Manager
Kingsman Scientific Management
5月 2019 - 9月 2020
学歴
PhD, Biochemistry
McMaster University
9月 2019 - 12月 2024
Masters of Biomedical Technology
Univerity of Calgary
9月 2018 - 8月 2019
Bachelors in Science (Biochemistry)
McMaster University
9月 2013 - 4月 2018
認定資格
- 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
Kinga Vojnits, Zhuohang Feng, Paige Johnson, Deanna Porras, Ekta Manocha, Sean Vandersluis, Sibylle Pfammatter, Pierre Thibault, Mick Bhatia (2024). Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs . Cancer Letters.
Allison L. Boyd, Justin Lu, Cameron G. Hollands, Lili Alsostovar, Shiva Murali, Jennifer C. Reid, Wendy Ye, Sean Vandersluis, Paige Johnson, Amro ElRafie, et al. (2023). Leukemic progenitor compartment serves as a prognostic measure of cancer stemness in patients with acute myeloid leukemia . Cell Reports Medicine.
Sean Vandersluis, Jennifer C. Reid, Luca Orlando, Mickie Bhatia (2022). Evidence-based support for phenotypic drug discovery in acute myeloid leukemia . Drug Discovery Today.